8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)
Published . Updated .
Key takeaways
- 8-K - Arcturus Therapeutics Holdings filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: ARCT
- Market reaction: ARCT −0.3% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Arcturus Therapeutics Holdings filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- ARCT Arcturus Therapeutics Holdings-41.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Arcturus Therapeutics Holdings belongs to, so it often moves with news about it.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+12.0% 30d
AbbVie is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.5% 30d
Merck is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+10.0% 30d
Abbott Laboratories is a peer of Arcturus Therapeutics Holdings in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ARCT | +17.59% | +1.93% | base | +10.86% | +1.60% | +0.64% | -0.27% |
| XLV | -0.05% | -0.52% | base | -0.06% | +1.85% | +2.11% | +2.13% |
| LLY | +3.64% | +3.08% | base | -0.91% | +3.29% | +4.76% | +5.16% |
| JNJ | +0.29% | -2.31% | base | +1.42% | +3.55% | +3.05% | +2.89% |
| ABBV | +2.38% | -0.72% | base | +1.24% | +1.86% | +2.05% | +2.40% |
| MRK | +1.80% | -1.52% | base | -0.09% | +1.25% | +0.75% | +0.21% |
| ABT | -6.44% | -3.65% | base | -3.14% | -2.67% | -2.73% | -3.67% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001193805-26-001439 Size: 264 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Arcturus Therapeutics Holdings (ARCT) has moved since 5 Nov 2026
Since the first closing price after “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer),” Arcturus Therapeutics Holdings (ARCT) is -18.45%.
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | +1.24% | final price |
| ABBV | the next day | +1.86% | final price |
| ABBV | two days later | +2.05% | final price |
| ABBV | three days later | +2.40% | final price |
| ABBV | three days earlier | -0.72% | final price |
| ABBV | five days earlier | +2.38% | final price |
| ABT | that day | -3.14% | final price |
| ABT | the next day | -2.67% | final price |
| ABT | two days later | -2.73% | final price |
| ABT | three days later | -3.67% | final price |
| ABT | three days earlier | -3.65% | final price |
| ABT | five days earlier | -6.44% | final price |
| Arcturus Therapeutics Holdings (ARCT) | that day | +10.86% | final price |
| Arcturus Therapeutics Holdings (ARCT) | the next day | +1.60% | final price |
| Arcturus Therapeutics Holdings (ARCT) | two days later | +0.64% | final price |
| Arcturus Therapeutics Holdings (ARCT) | three days later | -0.27% | final price |
| Arcturus Therapeutics Holdings (ARCT) | three days earlier | +1.93% | final price |
| Arcturus Therapeutics Holdings (ARCT) | five days earlier | +17.59% | final price |
| JNJ | that day | +1.42% | final price |
| JNJ | the next day | +3.55% | final price |
| JNJ | two days later | +3.05% | final price |
| JNJ | three days later | +2.89% | final price |
| JNJ | three days earlier | -2.31% | final price |
| JNJ | five days earlier | +0.29% | final price |
| LLY | that day | -0.91% | final price |
| LLY | the next day | +3.29% | final price |
| LLY | two days later | +4.76% | final price |
| LLY | three days later | +5.16% | final price |
| LLY | three days earlier | +3.08% | final price |
| LLY | five days earlier | +3.64% | final price |
| MRK | that day | -0.09% | final price |
| MRK | the next day | +1.25% | final price |
| MRK | two days later | +0.75% | final price |
| MRK | three days later | +0.21% | final price |
| MRK | three days earlier | -1.52% | final price |
| MRK | five days earlier | +1.80% | final price |
| XLV | that day | -0.06% | final price |
| XLV | the next day | +1.85% | final price |
| XLV | two days later | +2.11% | final price |
| XLV | three days later | +2.13% | final price |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 2 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 16 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 29 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 29 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 52 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 78 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 29 days before publication. Filed 5 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Arcturus Therapeutics Holdings (ARCT)
Companies tied to this story
- ARCT Arcturus Therapeutics Holdings
In “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer),” Arcturus Therapeutics Holdings (ARCT) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ARCT
Arcturus Therapeutics Holdings (ARCT)
Arcturus Therapeutics Holdings (ARCT) is the company in “8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer),” the 5 Nov 2026 this story story.
Arcturus Therapeutics Holdings (ARCT) is on the page because SEC 8-K filing -> direct issuer disclosure -> ARCT
Price levels for Arcturus Therapeutics Holdings (ARCT)
ARCT traded between 8.42 and 15.15 across 20 sessions. The latest close on file is 8.44.
What the saved facts support for Arcturus Therapeutics Holdings (ARCT)
14 out of 100
“8-K - Arcturus Therapeutics Holdings Inc. (0001768224) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.